Abstract
The mechanism of the renal excretion of carumonam (CRMN) was investigated in rats, rabbits, dogs, and monkeys. Stop-flow analysis in dogs demonstrated that CRMN is exclusively excreted by glomerular filtration. There was no specific CRMN peak corresponding to the peak of p-aminohippuric acid (PAH) secretion or to the trough of Na+-K+ reabsorption in the stop-flow pattern. Although the PAH peak disappeared when probenecid was administered, the CRMN stop-flow pattern showed no change. In rabbits, however, the CRMN concentration peak corresponding with the PAH peak was detected in the stop-flow pattern; the CRMN peak disappeared when probenecid was administered. The pharmacokinetic parameters in plasma, such as the area under the concentration-time curve, the half-life, and the clearance rate, were affected by probenecid in rats, rabbits, and monkeys, but not in dogs. The results suggest that the renal excretion of CRMN in dogs takes place exclusively through glomerular filtration. In rats, rabbits, and monkeys, however, CRMN is excreted through both glomerular filtration and renal tubular secretion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Imada A., Kondo M., Okonogi K., Yukishige K., Kuno M. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother. 1985 May;27(5):821–827. doi: 10.1128/aac.27.5.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kita Y., Fugono T., Imada A. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother. 1986 Jan;29(1):127–134. doi: 10.1128/aac.29.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MALVIN R. L., WILDE W. S., SULLIVAN L. P. Localization of nephron transport by stop flow analysis. Am J Physiol. 1958 Jul;194(1):135–142. doi: 10.1152/ajplegacy.1958.194.1.135. [DOI] [PubMed] [Google Scholar]
- Mizuta E., Tsubotani A. Preparation of mean drug concentration--time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters. Chem Pharm Bull (Tokyo) 1985 Apr;33(4):1620–1632. doi: 10.1248/cpb.33.1620. [DOI] [PubMed] [Google Scholar]
- Murakawa T., Nakamoto S., Nishida M. [Mechanism of renal excretion of ceftizoxime in rabbits and dogs (author's transl)]. Jpn J Antibiot. 1980 Jun;33(6):679–684. [PubMed] [Google Scholar]
- SCHREINER G. E. Determination of inulin by means of resorcinol. Proc Soc Exp Biol Med. 1950 May;74(1):117–120. doi: 10.3181/00379727-74-17827. [DOI] [PubMed] [Google Scholar]
- Shimada J., Yamaji T., Miyahara T., Ueda Y., Kawabata T., Sugeno K., Yoshida T., Nakamura M. Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis. Antimicrob Agents Chemother. 1983 Jan;23(1):8–14. doi: 10.1128/aac.23.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waugh W. H., Beall P. T. Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int. 1974 Jun;5(6):429–436. doi: 10.1038/ki.1974.61. [DOI] [PubMed] [Google Scholar]
- Weidekamm E., Stoeckel K., Egger H. J., Ziegler W. H. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrob Agents Chemother. 1984 Dec;26(6):898–902. doi: 10.1128/aac.26.6.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshida K., Mitani M., Naeshiro I., Torii H., Tanayama S. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Antimicrob Agents Chemother. 1986 Jun;29(6):1017–1024. doi: 10.1128/aac.29.6.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]